Autologous Stem Cell Transplantation for Multiple Myeloma

Wednesday, Sept 22nd
2:00 PM - 3:00 PM (ET)

 

Join us for a FREE one hour webinar! Learn about how autologous stem cell transplantation (ASCT) is used in multiple myeloma treatment. Participants will learn who is eligible for this procedure, how stem cells are collected and stored, what steps are involved, and what to expect in the recovery process. 

 

 

Autologous Stem Cell Transplantation in Multiple Myeloma

CELEBRATING 20 YEARS OF ARCHITECTURAL EXCELLENCE.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt.
 

MMRF Patient Webinar:
Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

EVENT DETAILS

 Currently, induction therapy followed by high-dose melphalan (HDM) and ASCT is the standard of care for the majority of patients with newly diagnosed multiple myeloma. ASCT can provide long and deep remissions (that is, periods in which there are no symptoms of myeloma or signs that any abnormal plasma cells are present). In this webinar, you will learn about how ASCT is used in multiple myeloma treatment. Participants will learn who is eligible for this procedure, how stem cells are collected and stored, what steps are involved, and what to expect in the recovery process.

EVENT FACULTY

OUR SPONSORS